搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ureaplasma parvum serovar 3 UPF0122 protein UPA3_0148 (UPA3_0148) CSB-YP534070UBK
CSB-EP534070UBK
CSB-BP534070UBK
CSB-MP534070UBK
CSB-EP534070UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Phosphate acyltransferase (plsX) CSB-YP534071UBK
CSB-EP534071UBK
CSB-BP534071UBK
CSB-MP534071UBK
CSB-EP534071UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L20 (rplT) CSB-YP534072UBK
CSB-EP534072UBK
CSB-BP534072UBK
CSB-MP534072UBK
CSB-EP534072UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L2 (rplB) CSB-YP534073UBK
CSB-EP534073UBK
CSB-BP534073UBK
CSB-MP534073UBK
CSB-EP534073UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 30S ribosomal protein S17 (rpsQ) CSB-YP534074UBK
CSB-EP534074UBK
CSB-BP534074UBK
CSB-MP534074UBK
CSB-EP534074UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 30S ribosomal protein S8 (rpsH) CSB-YP534075UBK
CSB-EP534075UBK
CSB-BP534075UBK
CSB-MP534075UBK
CSB-EP534075UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L15 (rplO) CSB-YP534076UBK
CSB-EP534076UBK
CSB-BP534076UBK
CSB-MP534076UBK
CSB-EP534076UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L17 (rplQ) CSB-YP534077UBK
CSB-EP534077UBK
CSB-BP534077UBK
CSB-MP534077UBK
CSB-EP534077UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Histidine--tRNA ligase (hisS) CSB-YP534078UBK
CSB-EP534078UBK
CSB-BP534078UBK
CSB-MP534078UBK
CSB-EP534078UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Cytidylate kinase (cmk) CSB-YP534079UBK
CSB-EP534079UBK
CSB-BP534079UBK
CSB-MP534079UBK
CSB-EP534079UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Aspartate--ammonia ligase (asnA) CSB-YP534080UBK
CSB-EP534080UBK
CSB-BP534080UBK
CSB-MP534080UBK
CSB-EP534080UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 UvrABC system protein C (uvrC), partial CSB-YP534081UBK
CSB-EP534081UBK
CSB-BP534081UBK
CSB-MP534081UBK
CSB-EP534081UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Heat-inducible transcription repressor HrcA (hrcA) CSB-YP534082UBK
CSB-EP534082UBK
CSB-BP534082UBK
CSB-MP534082UBK
CSB-EP534082UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Urease accessory protein UreF (ureF) CSB-YP534083UBK
CSB-EP534083UBK
CSB-BP534083UBK
CSB-MP534083UBK
CSB-EP534083UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP534084UBK
CSB-EP534084UBK
CSB-BP534084UBK
CSB-MP534084UBK
CSB-EP534084UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP534085UBK
CSB-EP534085UBK
CSB-BP534085UBK
CSB-MP534085UBK
CSB-EP534085UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Threonine--tRNA ligase (thrS), partial CSB-YP534086UBK
CSB-EP534086UBK
CSB-BP534086UBK
CSB-MP534086UBK
CSB-EP534086UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP534087UBK
CSB-EP534087UBK
CSB-BP534087UBK
CSB-MP534087UBK
CSB-EP534087UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 tRNA (guanine-N (1)-)-methyltransferase CSB-YP534088UBK
CSB-EP534088UBK
CSB-BP534088UBK
CSB-MP534088UBK
CSB-EP534088UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ureaplasma parvum serovar 3 50S ribosomal protein L34 (rpmH) CSB-YP534089UBK
CSB-EP534089UBK
CSB-BP534089UBK
CSB-MP534089UBK
CSB-EP534089UBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>